APOC-III-directed RNA Interaction drugs

2 medications in the FDA established pharmacologic class “APOC-III-directed RNA Interaction”.

DrugTypeNDC products
Tryngolza
olezarsen sodium		Rx2
Redemplo
plozasiran		Rx1